Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma

By Higashijima T.   Kataoka A.   Nishida T.   Yakushiji M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 169-173

Elsevier

Access to resources Recommend Favorite

Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist

By Yu K.-J.   Lai C.-R.   Sheu M.-H.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 96, Iss. 2, 2001-06 ,pp. : 223-225

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial

By Vercellini P.   Trespidi L.   Zaina B.   Vicentini S.   Stellato G.   Crosignani P.G.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1390-1395

Elsevier

Access to resources Recommend Favorite

Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences

By Kadowaki M.   Murakami T.   Morita J.   Terada Y.   Yaegashi N.   Okamura K.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 1081-1082

Elsevier

Access to resources Recommend Favorite

Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist

By Efstathiadou Z.   Tsatsoulis A.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite